Evidence map›Paper›PMID 33014857›Full record

ArticleFrontiers in oncology2020

Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.

Xiaoqiang Liu, Zhengtao Zhou, Yibing Wang, Ke Zhu, Wen Deng, Yulei Li, Xiaochen Zhou, Luyao Chen, Yu Li, An Xie and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Virus, Exosome, and MicroRNA: New Insights into Autophagy.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Xiaoqiang LiuDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhengtao ZhouDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yibing WangDepartment of Emergency, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Ke ZhuDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Wen DengDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yulei LiDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xiaochen ZhouDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Luyao ChenDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yu LiDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
An XieJiangxi Institute of Urology, Nanchang, China.
Tao ZengDepartment of Urology, The People's Hospital of Jiangxi Province, Nanchang, China.
Gongxian WangDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Bin FuDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00589.].

Indexed as

autophagybladder cancerhigh-mobility group AT-hook 1 (HMGA1)miR-221TP53INP1

Identifiers

PMID33014857
PMCPMC7500478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.